These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 18391486

  • 1. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486
    [Abstract] [Full Text] [Related]

  • 2. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.
    Neurology; 2007 Jul 31; 69(5):459-69. PubMed ID: 17664405
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM, Donepezil MSAD Study Investigators Group.
    Int J Geriatr Psychiatry; 2005 Jun 31; 20(6):559-69. PubMed ID: 15920715
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 31; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 5. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V, Haglund A, Kowalski J, Langworth S, Winblad B.
    Dement Geriatr Cogn Disord; 2008 Dec 31; 26(5):458-66. PubMed ID: 18984956
    [Abstract] [Full Text] [Related]

  • 6. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.
    Neurology; 2009 May 05; 72(18):1555-61. PubMed ID: 19176895
    [Abstract] [Full Text] [Related]

  • 7. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2009 May 05; 27(3):232-9. PubMed ID: 19246907
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis.
    Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J.
    J Alzheimers Dis; 2010 May 05; 21(3):843-51. PubMed ID: 20634594
    [Abstract] [Full Text] [Related]

  • 10. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R.
    Curr Med Res Opin; 2006 Mar 05; 22(3):483-94. PubMed ID: 16574032
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A, Gauthier S, Perdomo C.
    Int J Geriatr Psychiatry; 2007 Aug 05; 22(8):806-12. PubMed ID: 17199235
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
    Wilkinson D, Andersen HF.
    Dement Geriatr Cogn Disord; 2007 Aug 05; 24(2):138-45. PubMed ID: 17622761
    [Abstract] [Full Text] [Related]

  • 13. Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.
    Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P, Donepezil MSAD Study Investigators' Group.
    Curr Med Res Opin; 2002 Aug 05; 18(6):347-54. PubMed ID: 12442882
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial.
    Seltzer B, Zolnouni P, Nunez M, Goldman R, Kumar D, Ieni J, Richardson S, Donepezil "402" Study Group.
    Arch Neurol; 2004 Dec 05; 61(12):1852-6. PubMed ID: 15596605
    [Abstract] [Full Text] [Related]

  • 15. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M, Ichimiya Y, Nozawa E, Utumi Y, Sugiyama H, Murayama N, Iseki E, Arai H.
    Psychogeriatrics; 2009 Jun 05; 9(2):50-5. PubMed ID: 19604325
    [Abstract] [Full Text] [Related]

  • 16. Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials.
    Winblad B, Black SE, Homma A, Schwam EM, Moline M, Xu Y, Perdomo CA, Swartz J, Albert K.
    Curr Med Res Opin; 2009 Nov 05; 25(11):2577-87. PubMed ID: 19735164
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P, Tsolaki M, Hort J, Hager K, Soininen H, López Pousa S, Li C, Schwam E.
    Curr Med Res Opin; 2007 Dec 05; 23(12):3153-65. PubMed ID: 17988434
    [Abstract] [Full Text] [Related]

  • 18. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
    Wattmo C, Hansson O, Wallin AK, Londos E, Minthon L.
    Dement Geriatr Cogn Disord; 2008 Dec 05; 26(3):203-11. PubMed ID: 18769065
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.
    Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A.
    Clin Ther; 2010 Jul 05; 32(7):1234-51. PubMed ID: 20678673
    [Abstract] [Full Text] [Related]

  • 20. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
    Hashimoto M, Yatabe Y, Kaneda K, Honda K, Ikeda M.
    Psychogeriatrics; 2009 Dec 05; 9(4):196-203. PubMed ID: 20377821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.